Ian D Pavord Selected Research

Angiotensin Receptor Antagonists

10/2020

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ian D Pavord Research Topics

Disease

162	Asthma (Bronchial Asthma) 04/2024 - 04/2002
55	Inflammation (Inflammations) 02/2024 - 12/2002
37	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 10/2003
16	Cough 01/2022 - 01/2003
11	Chronic Cough 01/2023 - 01/2004
9	Eosinophilia 03/2022 - 01/2005
7	COVID-19 10/2022 - 01/2020
7	Bronchitis 08/2006 - 05/2002
6	Infections 01/2023 - 08/2020
4	Rhinosinusitis 01/2023 - 01/2020
4	Pneumonia (Pneumonitis) 08/2020 - 06/2015
4	Respiratory Hypersensitivity 11/2013 - 12/2002
3	Airway Remodeling 03/2024 - 01/2019
2	Hypersensitivity (Allergy) 11/2023 - 05/2019
2	Obesity 01/2023 - 01/2022
2	Airway Obstruction (Choking) 11/2022 - 01/2020
2	Cystic Fibrosis (Mucoviscidosis) 09/2021 - 03/2016
2	Lung Diseases (Lung Disease) 01/2021 - 09/2010
2	Atopic Dermatitis (Atopic Eczema) 01/2020 - 05/2018
2	Obstructive Lung Diseases (Obstructive Lung Disease) 11/2019 - 01/2016
2	Cough-Variant Asthma 01/2004 - 01/2004
1	Body Weight (Weight, Body) 01/2024
1	Respiratory Sounds (Crackle) 01/2023
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2022
1	Symptom Flare Up 01/2022

Drug/Important Bio-Agent (IBA)

85	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 01/2003
59	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2005
34	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2024 - 01/2005
26	dupilumabIBA 03/2024 - 01/2018
26	mepolizumabIBA 03/2024 - 03/2009
19	Bronchodilator Agents (Bronchodilators)IBA 04/2024 - 02/2006
18	Monoclonal AntibodiesIBA 12/2023 - 08/2012
13	CytokinesIBA 12/2023 - 12/2002
12	Immunoglobulin E (IgE)IBA 01/2024 - 12/2010
12	Interleukin-13IBA 01/2022 - 11/2004
11	Interleukin-5 (Interleukin 5)IBA 03/2024 - 10/2013
9	InterleukinsIBA 11/2023 - 08/2012
8	Formoterol Fumarate (Oxis)FDA Link 04/2024 - 05/2009
8	SteroidsIBA 06/2023 - 08/2012
8	GlucocorticoidsIBA 10/2021 - 09/2014
7	Interleukin-4 (Interleukin 4)IBA 10/2022 - 12/2002
6	Budesonide (Pulmicort)FDA LinkGeneric 04/2024 - 05/2009
6	Capsaicin (Zostrix)FDA Link 01/2016 - 02/2005
5	Prednisolone (Predate)FDA LinkGeneric 06/2023 - 09/2014
5	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 11/2015
5	Fluticasone (Cutivate)FDA LinkGeneric 01/2019 - 04/2006
4	fluticasone furoate FDA Link 02/2024 - 06/2015
4	GefapixantIBA 01/2023 - 10/2020
4	Azithromycin (Zithromax)FDA LinkGeneric 11/2022 - 07/2019
4	benralizumabIBA 01/2022 - 08/2015
4	Salmeterol Xinafoate (Serevent)FDA Link 02/2016 - 04/2006
4	Methacholine Chloride (Methacholine)FDA Link 11/2013 - 04/2002
3	tezepelumabIBA 04/2024 - 11/2023
3	Albuterol (Salbutamol)FDA LinkGeneric 04/2024 - 01/2019
3	vilanterolIBA 02/2024 - 06/2015
3	C-Reactive ProteinIBA 10/2021 - 01/2014
3	fevipiprantIBA 01/2021 - 01/2016
3	GoldIBA 07/2019 - 01/2018
2	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 10/2023 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 07/2021
2	LeukotrienesIBA 01/2023 - 11/2013
2	Prostaglandin D2IBA 10/2022 - 01/2004
2	anti-IgE antibodiesIBA 01/2022 - 01/2011
2	Omalizumab (Xolair)FDA Link 01/2022 - 01/2016
2	reslizumabIBA 01/2022 - 08/2015
2	Purinergic P2X3 ReceptorsIBA 01/2022 - 10/2020
2	Antiviral Agents (Antivirals)IBA 10/2021 - 08/2020
2	prostaglandin D2 receptorIBA 01/2021 - 01/2016
2	Prednisone (Sone)FDA LinkGeneric 01/2020 - 11/2013
2	LipidsIBA 01/2019 - 01/2018
2	ChemokinesIBA 01/2018 - 08/2006
2	Beclomethasone (Beclometasone)FDA Link 02/2011 - 08/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007 - 02/2006
2	Etanercept (Enbrel)FDA Link 01/2007 - 02/2006
2	Chemokine ReceptorsIBA 09/2005 - 12/2002
1	Carbon DioxideIBA 04/2024
1	Therapeutic UsesIBA 03/2024
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2024
1	GSK573719IBA 02/2024
1	Muscarinic AntagonistsIBA 02/2024
1	Immunoglobulins (Immunoglobulin)IBA 12/2023
1	Thymic Stromal LymphopoietinIBA 12/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	Nicotine FDA Link 10/2022
1	Leukotriene E4IBA 10/2022
1	neuromedin UIBA 01/2022
1	Reducing AgentsIBA 01/2022
1	AntibodiesIBA 01/2022
1	LigandsIBA 01/2022
1	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2022

Therapy/Procedure

53	Therapeutics 04/2024 - 01/2003
14	Biological Therapy 01/2024 - 01/2016
8	Bronchial Thermoplasty 01/2016 - 03/2007
5	Drug Therapy (Chemotherapy) 10/2021 - 01/2018
4	Precision Medicine 01/2021 - 02/2016
2	Metered Dose Inhalers (Metered Dose Inhaler) 04/2024 - 01/2019
2	Length of Stay 07/2021 - 01/2016
2	Nebulizers and Vaporizers (Inhaler) 01/2021 - 01/2020
2	Drug Tapering 12/2014 - 08/2008
1	Dry Powder Inhalers 04/2024